The FDA expanded the approval of Pluvicto (lutetium Lu 177 vipivotide tetraxetan) to include patients with PSMA-positive mCRPC who have been treated with ARPI therapy and are considered appropriate to ...

The FDA has approved Imfinzi® (durvalumab), in combination with gemcitabine and cisplatin, for the treatment of adult patients with MIBC.

More than 2 decades have passed since I became the first full-time editor of Renal & Urology News. During that time, the ...

(HealthDay News) — A wearable T-shirt monitor can help oncological urology patients return home sooner after robotic-assisted surgery, according to a study presented at the 40th annual European ...

(HealthDay News) — Avoidable mortality is increasing in the United States and decreasing in comparator countries, according to a study published online March 24 in JAMA Internal Medicine.

(HealthDay News) — A Chinese woman is the third person in the world living with a gene-edited pig kidney, and nearly 3 weeks after surgery, doctors say she’s doing well. The woman, reportedly ...

The provision of physician control over aspects of their clinical work environment should be considered to reduce burnout and improve retention. Poor control over specific aspects of work was ...

Maintaining systolic blood pressure consistently below 130 mmHg could help decrease the risk for new-onset diabetes in the general elderly population. Hypertension and female sex increase the risk ...

Pembrolizumab plus docetaxel does not improve radiographic progression-free survival or overall survival compared with docetaxel alone. Adding pembrolizumab to docetaxel is not better than ...